罗他霉素抗感染31例

EFFICACY OF ROKITAMYCIN IN THE TREATMENT OF INFECTIOUS DISEASES

用罗他霉素及对照药美欧卡霉素治疗感染性疾病患者分别为３１例、３０例，总有效率（痊愈＋显效）分别为８７．０９％、７３．３３％，结果表明罗他霉素疗效与美欧卡霉素无明显差异，治疗组中除１例ＡＬＴ轻度增高外，余无明显不良反应，提示罗他霉素有较好的临床应用价值。

patients with infectious diseases were randomly divided to receive rokitamycin and miocamycin. The response rate in rokitamycin group was 87.09% (27/31) with mild side effects,and in miocamycin group was 73.33%(22/30).There is no significant difference between the two groups.Rokitamycin could be used as a new agent in clinic.